Transcutaneous Intratracheal Delivery
Transcutaneous Intratracheal Delivery - Related Videos
08:00
Intubation-mediated Intratracheal (IMIT) Instillation: A Noninvasive, Lung-specific Delivery System
0 Views •
Cited by 34 •
2014
Intubation-mediated intratracheal (IMIT) instillation of reagents is an excellent, noninvasive method for studying respiratory disease, as well as a method for instilling therapeutic reagents directly into the lung. It is a rapid and highly reproducible method which is suitable for preclinical testing.
02:22
Performing Intratracheal Bacterial Delivery in a Mouse Model
0 Views •
2025
Source: Venuprasad, K., et al. Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation. J. Vis. Exp. (2016)This video demonstrates the intratracheal delivery of a lung-pathogenic bacterial inoculum into an anesthetized mouse to model lower respiratory tract infection.
06:09
Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
0 Views •
Cited by 2 •
2017
This protocol describes intratracheal inoculations of Fischer 344 rats with Francisella tularensis. This procedure mimics pulmonary exposure of humans to this potential biothreat agent and can be used to test vaccine and therapeutic efficacy against pulmonary tularemia.
06:27
Transcutaneous Microcirculatory Imaging in Preterm Neonates
0 Views •
Cited by 6 •
2015
Microcirculatory imaging (MI) is used to monitor peripheral perfusion in critically ill or preterm neonates. This manuscript and video demonstrates the optimal approach for obtaining high-quality images.
07:18
Transcutaneous Assessment of Renal Function in Conscious Rodents
0 Views •
Cited by 34 •
2016
Determination of glomerular filtration rate (GFR) is the gold standard to assess overall kidney function. However, traditional procedures to measure this parameter are cumbersome and require a large investment of time. Here we describe a faster and minimally invasive method to determinate GFR transcutaneously.
FAQs
The tracheal lumen provides a direct access point to the lower respiratory tract, but local anatomy can influence where the administered material travels and remains. Because the route bypasses the upper airway, distribution begins within the trachea rather than at structures that might otherwise affect initial deposition. This makes anatomical considerations important when interpreting delivery patterns.
Ventilation helps disperse the delivered substance through the airway after it reaches the tracheal lumen. The resulting distribution is therefore not determined solely by the placement site; airflow contributes to how widely the material spreads through the lower respiratory tract. This mechanism supports targeted pulmonary administration while making ventilation relevant to experimental interpretation and treatment response.
Formulation characteristics and airway clearance influence how long a substance remains available within the respiratory tract and where it is found after administration. A formulation may disperse differently from another, while clearance can reduce local retention over time. Considering both factors helps researchers evaluate delivery consistency, persistence, and the relationship between administration and pulmonary effects.
Transcutaneous intratracheal delivery reduces dependence on upper-airway deposition by placing the material directly within the tracheal lumen. This changes the initial access point for lower-respiratory delivery and can provide a more controlled route for pulmonary investigations. The distinction matters when researchers need to separate effects associated with direct airway placement from those influenced by upper-airway distribution.
Administration requires a needle or catheter that passes through the skin and tracheal wall into the tracheal lumen. The selected instrument provides the physical pathway for introducing a therapeutic or experimental substance at the intended airway site. In research workflows, this hardware is central to establishing direct lower-respiratory access before ventilation disperses the material.
The procedure centers on positioning a needle or catheter through the skin and tracheal wall, introducing the selected substance into the tracheal lumen, and allowing ventilation to support airway distribution. Interpretation then considers local anatomy, formulation, and airway clearance. These elements connect the physical delivery step with the material’s subsequent dispersal and retention.
Researchers may use transcutaneous intratracheal delivery to investigate localized administration of drugs, biologics, and other experimental formulations in the lower respiratory tract. It can support studies of pulmonary therapies, respiratory disease mechanisms, and treatment responses. The route is especially relevant when a controlled method for examining direct airway exposure is needed.
This approach can help investigators examine how a pulmonary formulation distributes, persists, and produces a treatment response after direct tracheal administration. By relating delivery conditions to airway exposure, researchers can study respiratory disease mechanisms and evaluate experimental therapies. Its value lies in connecting a controlled administration route with observable pulmonary outcomes.